Business Context and Reporting Period
Company: enVVeno Medical Corporation (NVNO)
Filing Type: Form 8-K (Current Report)
Date of Report: October 7, 2025
Reporting Period: Event-based notification regarding Nasdaq listing compliance.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on regulatory compliance regarding stock price.
Material Changes
The Company received notification from The Nasdaq Stock Market LLC that its common stock no longer complies with the minimum bid price requirement for continued listing under Rule 5550(a)(2). The closing bid price has fallen below $1.00 per share for 30 consecutive business days.
Outlook, Risks, and Contingencies
- Compliance Period: The Company has 180 calendar days from the notification date (until April 6, 2026) to regain compliance.
- Compliance Criteria: The closing bid price must close at or above $1.00 per share for a minimum of 10 consecutive trading days prior to April 6, 2026.
- Secondary Compliance Period: If compliance is not met by April 6, 2026, the Company may be eligible for an additional 180-day period. Qualification requires meeting the market value of publicly held shares and all other initial listing standards, potentially necessitating a reverse stock split.
- Delisting Risk: Failure to cure the deficiency or qualify for an extension may result in delisting. The Company retains the right to appeal a delisting determination.
- Immediate Impact: The notice has no immediate effect on the listing status of the common stock.
Investor Verification Checklist
- Verify the current closing bid price of NVNO stock relative to the $1.00 threshold.
- Monitor the Company's announcement of a potential reverse stock split to regain compliance.
- Check for updates on the market value of publicly held shares to assess eligibility for the second compliance period.
- Review the Company's 10-K or 10-Q filings for the most recent financial data, as this 8-K contains no financial metrics.